Open Orphan subsidiary signs deal with global pharma company
Deal will see hVivo manufacture virus for use in human challenge studies
Venn Life Sciences wins another Covid-19 drug study
Open Orphan subsidiary to manage Phase 2 clinical trial for European pharma company
Open Orphan signs two year contract with German pharma company
Contract guarantees annual revenue for Dublin listed company
Open Orphan eyes profitability as it reports £4.1m ebitda loss
Company led by Cathal Friel recorded revenues of £7.1m for its first half
Open Orphan wins contract to support European pharma giant
Paris subsidiary Venn Life Sciences to work with oncology study enrolling 750 subjects
Open Orphan signs deal to carry out Covid-19 vaccine trial
Dublin listed company will carry out phase one trial at Hvivo facility
Open Orphan signs option to acquire company for ‘nominal sum’
The pharmaceutical company has three months to acquire CHIMagents
Open Orphan develops first challenge study model to test Covid-19 vaccines
Dublin-listed pharmaceutical services company publishes annual results for 2019
Open Orphan signs big deal with vaccine manufacturer
Agreement covers market access of newly developed medicine into EU and US markets
Open Orphan launches Covid-19 antibody testing service
London subsidiary Hvivo will carry out testing at its lab with 48-hour turnaround
Open Orphan raises €13.4m to ramp up Covid-19 study
Challenge study models could speed up the development of a vaccine by up to three years
Covid-19: Open Orphan to carry out 3,000 antibody tests per day
Antibody tests can detect if a person has had coronavirus before and has since recovered
Irish companies come out in force to help during Covid-19 pandemic
Issues with everything from drug trials to tech solutions, patient care are being tackled
Open Orphan to ‘boost revenue’ with new contract
Pharma services company to build on an existing relationship with German company
Open Orphan to merge with UK-based Hvivo in £30m tie-up
Deal values Hvivo at £12.96m, with its shareholders owning 44.7% of enlarged company
Irish skincare company Integumen raising €1.6m from share placing
Company to use funds to help boost revenues as it looks to double size of its laboratory
Open Orphan posts maiden loss as listed company
Pharma services business completed reverse takeover of Venn Life Sciences in June
Open Orphan resumes trading on markets following merger
Company chief executive Cathal Friel says it has ‘a clear growth strategy’ for shareholders
Venn Life Sciences to pursue ‘build to sell’ plan after merger
Combined group to fall under Open Orphan name
Cathal Friel reverses Open Orphan into listed Venn Life Sciences
Clinical trials group issues profit warning alongside results ahead of merger
Canadian pharma company appoints Dublin man to lead new Europe operation
Theratechnologies has appointed Conor Walshe to the role of general manager
Venn signs deal with Open Orphan to focus on rare diseases
Company has issued €1.1m in loan notes to fund specialisation in orphan diseases
Big Pharma bids to build bridges in Ireland
Irish industry’s chief looks for partnership as he admits trust is lacking
Venn shares hit new low as sales slide 15%
Clinical trials group falls to a loss but is optimistic for the future
European expansion on the cards for life sciences company
EY Entrepreneur of the Year finalist Tony Richardson, Venn Life Sciences
Venn Life Sciences raises £650,000 in share sale
Proceeds to be used for the acquisition by Venn Germany of CRM Biometrics
Losses for Venn Life Sciences as Integumen charges hit But
But earnings before interest, tax and exceptional items rose for the year
EY Entrepreneur of the Year: 24 companies shortlisted for award
Finalists employ more than 2,700 people and generate annual revenues of €150m
Venn Life Sciences reports rise in earnings despite fall in revenue
Irish drug development group targeting ‘higher value customer markets’
Revenue continues to rise at Venn Life Sciences
New financial year ‘started well’ with contract wins of €5.7m for clinical trials group
Dublin-based Venn Life Sciences records 57% rise in 2016 income
Firm says it secured €5.7 million worth of contract deals in first two months of 2017
No women directors, no problem, or so the view appears within Ireland Inc
Caveat: No gender quotas and no improvement in women director numbers
Venn Life Sciences wins €2.5m clinical trials contract
Company to carry out phase III study on behalf of Swedish firm Sedana Medical
Income more than doubles at clinical trials group Venn
Investment in synthetic skin project that is being sold widens operating loss
What’s coming up in the week ahead
Post-Brexit opportunities for trade and a showcase for Irish tourism feature in this week’s business diary
Sales surge at clinical trials group Venn Life Sciences
Company reports maiden Ebitda profit before exceptionals on strong sales and Kinesis acquisition
Revenue at Clinical trials group Venn will be ‘significantly’ over €10m
Venn Life Sciences expects to exceed current market expectations by at least 15%
Dublin-based Venn Life Sciences wins dual-listing approval
Venn approved to trade shares on Irish Stock Exchange’s ESM as well as on AIM
Venn Life Sciences signs contracts worth over €3.4m
Contracts with US biotech firm are extensions of an existing Phase II programme
Venn Life Sciences to acquire Kinesis Pharma for €6.5m
Dublin-based clinical research group reports first-half revenues of €4.29 million
Venn Life Sciences reports huge jump in revenues
AIM-listed Irish company says revenues rose by 140% last year
Venn Life Sciences expects full-year revenue to increase 100% on 2013
Clinical research group has won contracts worth more than €8m since May
Venn Life Sciences reports 32% rise in revenue on back of new contracts
Clinical trials group continues to integrate acquisitions and eye new targets
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices